Download PDF
Thromb Haemost 1978; 40(02): 407-417
DOI: 10.1055/s-0038-1648674
Original Article
Schattauer GmbH Stuttgart

Heparin from Intestine and Lung Source Administered in Large Dose to Dogs with Acute Myocardial Ischemia

Similar and Dissimilar Effects on Electrocardiograms and Adenosine Triphosphate
Michael J Saliba Jr
The Community Medicine Department, University of California, San Diego, U.S.A.
,
Richard J Pavalec
The Community Medicine Department, University of California, San Diego, U.S.A.
› Author Affiliations
Further Information

Publication History

Received 20 September 1977

Accepted 10 February 1978

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Intestinal mucosa heparin (IMH) and beef lung heparin (BLH) were infused into dogs subjected to myocardial ischemia by intermittent coronary artery occlusions. The IMH was from a mixture of beef, sheep, and pig intestinal mucosa. Initial control occlusion and recovery was followed by a second occlusion with 60,000 units of IMH or BLH added. Electrocardiographic S-T segment elevations (ST) were measured acutely. There were no significant differences in ST in non-ischemic myocardium before occlusions or with occlusions. In ischemic myocardium, IMH significantly lowered control ST 84% in amount (t = 6.1 p <0.00005), and 76% in number (t = 11.6 p <0.00001). BLH lowered control ST a significant, lesser, 36% in amount (t = 3.6 p <0.008), and 35% in number (t = 3.2 p <0.01). The difference between IMH and BLH in ischemic myocardium was a significant 48% in amount (t = 4.0 p <0.0007), and 41% in number (t = 2.0 p <0.06). Myocardial adenosine triphosphate (ATP) levels were assayed after 90 min. ATP levels were 31% higher in both ischemic and non-ischemic myocardium in IMH-treated dogs than in BLH- treated. It was concluded that IMH and BLH are functionally different, and IMH was significantly more effective.

 

  • References

  • 1 Amann R, Werle E. 1956; Ober Komplexe von Heparin mit Histamin und anderen di- und polyamine. Klinische Wochenschrift 34: 207
    CrossrefPubMedGoogle Scholar
  • 2 Bates BJ, Diamond S, D’Agnostino BS. 1973; Comparison of anticoagulant activity of two preparations of purified heparin. Clinical Pharmacology and Therapeutics 14: 287
    PubMedGoogle Scholar
  • 3 Carleton RA, Sanders CA, Burack WR. 1960; Heparin administered after acute myocardial infarction. New England Journal Medicine 263: 1002
    CrossrefPubMedGoogle Scholar
  • 4 Drapkin A, Merskey C. 1972; Anticoagulant therapy after acute myocardial infarction. Journal American Medical Association 222: 541
    CrossrefPubMedGoogle Scholar
  • 5 Gillet MP T, Besterman EM M. 1973; Effects of heparin derived from different tissues on plasma-phospholipids and platelet aggregation. Lancet 2: 1204
    PubMedGoogle Scholar
  • 6 Gillford RH, Feinstein AR. 1969; A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction. New England Journal Medicine 280: 351
    CrossrefPubMedGoogle Scholar
  • 7 Gomez-Perez F. 1972; Anticoagulant activity of two commercially available heparin preparations. A controlled study Journal Clinical Pharmacology 12 (10) 413
    PubMedGoogle Scholar
  • 8 Holten C, Lundsteen E. 1942; The use of heparin in coronary thrombosis. Nordisk Medicine 13: 13
    PubMedGoogle Scholar
  • 9 Jacques LB, Ballieux RE, Van Arkel C. 1963; Microelectrophoresis of heparin. Acta medica Scandinavica 174: 717
    PubMedGoogle Scholar
  • 10 Kociba GJ. 1977. Disseminated intravascular coagulation. In: KIRK RW. (Ed.) Current Veterinary Therapy. 6. Ed Saunders Company; Philadelphia: p 448
    Google Scholar
  • 11 Levine WG. 1970. Heparin and oral anticoagulants. In: Goodman LS, Gilman A. (Ed.) The Pharmacological Basis of Therapeutics. 4. Ed MacMillan Company; New York: p 1450
    Google Scholar
  • 12 Manson DL, Fullerton HW. 1956; Anticoagulant therapy in cardiac infarction. British Medical Journal 1: 6
    CrossrefPubMedGoogle Scholar
  • 13 Novak E, Sekhar NC, Dunham NW. 1972; A comparative study of the effects of lung and gut heparin on platelet aggregation and protamine neutralization in man. Clinical Medicine 19 (07) 22
    PubMedGoogle Scholar
  • 14 Saliba Jr MJ, Griner LA. 1970; Heparin efficacy in bums. I. significant early modification of experimental third-degree guinea pig thermal burns and ancillary findings. Aerospace Medicine 41: 179
    PubMedGoogle Scholar
  • 15 Saliba Jr MJ, Dempsey WC, Kruggel JL. 1973; Large burns in humans; treatment with heparin. Journal American Medical Association 225: 261
    CrossrefPubMedGoogle Scholar
  • 16 Saliba Jr MJ, Saliba RJ. 1975; Heparin in burns: Dose related and dose depent effects. Thrombosis et Diathesis Haemorrhagica 33: 113
    PubMedGoogle Scholar
  • 17 Saliba Jr MJ, Covell JW, Bloor CM. 1976; a Effects of heparin in large doses on the extent of myocardial ischemia after acute coronary occlusion in the dog. American Journal of Cardiology 37: 599
    CrossrefPubMedGoogle Scholar
  • 18 Saliba Jr MJ, Kuzman WJ, Marsh DG. 1976; b Effects of heparin in anticoagulant doses on the electrocardiogramm and cardiac enzymes in patients with acute myocardial infarction. American Journal of Cardiology 37: 605
    CrossrefPubMedGoogle Scholar
  • 19 Seliger HH, Mcelroy WD. 1965. In: Seliger HH, Mcelroy WD. (Ed.) White, Physical And Biological Action. Academic Press; New York: p 367
  • 20 Schumacher Jr EE, Drake JR, Feenstra LH. 1962; Heparin and oral anticoagulants: comparison with special reference to acute myocardial infarction. American Journal of Cardiology 9: 568
    CrossrefPubMedGoogle Scholar
  • 21 Solandt DY, Best CH. 1938; Heparin and coronary thrombosis in experimental animals. Lancet 2: 130
    PubMedGoogle Scholar
  • 22 Solandt DY, Nassim R, Best CH. 1939; Production and prevention of cardiac mural thrombosis in dogs. Lancet 2: 592
    PubMedGoogle Scholar
  • 23 Walton PL, Ricketts CR, Bangham DR. 1966; Heterogeneity of heparin. British Journal of Haematology 12: 310
    CrossrefPubMedGoogle Scholar